LeafNLP Demos
Back to explore

Report #2886807

Received Feb 25, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNKUNKSC

Symptoms (1)

Incorrect route of product administration

Symptom narrative

Menveo SQ instead of IM; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of intramuscular formulation administered by other route in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo (subcutaneous). On an unknown date, an unknown time after receiving Menveo, the patient experienced intramuscular formulation administered by other route (Verbatim: Menveo SQ instead of IM). The outcome of the intramuscular formulation administered by other route was not applicable. Additional Information: GSK receipt date 20-FEB-2026 The pharmacist enquired whether vaccine should be readministered. The batch number was not provided and a request for this information has been made.